Selenium is an essential trace mineral that functions as a cofactor for 25 selenoproteins involved in antioxidant defense, thyroid hormone metabolism, and immune function. It exists in multiple forms including inorganic (sodium selenite), organic (selenomethionine from yeast), and nanoparticle formulations, with varying bioavailability and toxicity profiles. Selenium supplementation requires careful dosing as both deficiency and excess can cause serious health issues, with a narrow margin between therapeutic and toxic levels.

Overview

Selenium is an essential trace element that functions biologically through its incorporation into selenoproteins as the amino acid selenocysteine (the 21st amino acid), which is encoded by the UGA codon through a specialized translational machinery. The human selenoproteome comprises 25 selenoproteins, including the glutathione peroxidases (GPx1-4, GPx6) that reduce hydrogen peroxide and lipid hydroperoxides using glutathione as substrate, the thioredoxin reductases (TrxR1-3) that maintain the thioredoxin system critical for redox regulation and DNA synthesis, the iodothyronine deiodinases (DIO1-3) that convert inactive thyroxine (T4) to active triiodothyronine (T3), and selenoprotein P (SELENOP) that serves as the primary selenium transport protein and provides antioxidant protection to the vascular endothelium.

Selenium status profoundly influences thyroid function, immune competence, and cancer risk. The thyroid gland has the highest selenium concentration per gram of any organ, and selenium deficiency impairs T4-to-T3 conversion by deiodinases, potentially contributing to hypothyroid symptoms even with adequate iodine intake. Supplementation with selenomethionine or sodium selenite has been shown to reduce thyroid peroxidase antibodies (TPO-Ab) in Hashimoto's thyroiditis, suggesting immunomodulatory effects in autoimmune thyroid disease. For immunity, selenium enhances NK cell activity, T-cell proliferation, and antibody production, while deficiency increases susceptibility to viral infections — notably, selenium-deficient hosts allow benign viruses to mutate to virulent strains (as demonstrated with Coxsackievirus B3 in Keshan disease). The Nutritional Prevention of Cancer (NPC) trial initially suggested significant reductions in prostate, lung, and colorectal cancer incidence with selenium supplementation, though the subsequent larger SELECT trial found no benefit for prostate cancer with selenomethionine alone.

The optimal range for selenium is narrow, with both deficiency and excess carrying health risks. Dietary adequacy is achieved at 55-70 mcg/day (the RDA), with optimal selenoprotein expression occurring at plasma selenium concentrations of approximately 120 ng/mL. Supplementation beyond saturation of selenoprotein synthesis (above approximately 200 mcg/day) does not provide additional antioxidant benefit and may increase risks — the SELECT trial raised concerns about increased type 2 diabetes risk at 200 mcg/day in selenium-replete individuals. Toxicity (selenosis) occurs at intakes above 400 mcg/day, manifesting as garlic breath, hair loss, nail brittleness, and neurological symptoms. Supplemental forms include selenomethionine (organic, highest bioavailability), sodium selenite (inorganic), and selenium-enriched yeast. Selenium works synergistically with vitamin E for antioxidant protection, iodine for thyroid function, and zinc for immune support.

Mechanism of Action

Mechanism of Action

Selenium functions biologically through incorporation into selenoproteins as the amino acid selenocysteine (Sec), encoded by a UGA codon with a specialized mRNA stem-loop structure (SECIS element). The human selenoproteome comprises 25 selenoproteins with diverse redox functions.

Glutathione Peroxidase System

The GPx family (GPx1-6) represents the best-characterized selenoprotein function. GPx1 (cytoplasmic) and GPx4 (phospholipid hydroperoxide GPx) are particularly important. GPx4 uniquely reduces phospholipid hydroperoxides within membranes, making it essential for preventing ferroptosis (iron-dependent lipid peroxidation cell death). GPx4 deficiency is embryonically lethal, underscoring selenium's critical role in membrane integrity.

Thioredoxin Reductase System

TrxR1 (cytoplasmic) and TrxR2 (mitochondrial) maintain the thioredoxin system in its reduced state. This system provides electrons for ribonucleotide reductase (DNA synthesis), methionine sulfoxide reductases (protein repair), and peroxiredoxins (H2O2 detoxification). TrxR also directly reduces dehydroascorbate, lipoic acid, and ubiquinone, serving as a backup antioxidant pathway.

Thyroid Hormone Regulation

The thyroid contains the highest selenium concentration per gram of any organ. DIO1 and DIO2 catalyze outer-ring deiodination of T4 to T3, while DIO3 catalyzes inner-ring deiodination producing reverse T3. Selenium deficiency impairs T4-to-T3 conversion, contributing to hypothyroid symptoms even with normal T4 levels. Combined selenium and iodine deficiency produces more severe thyroid dysfunction than either alone.

Cancer Prevention Mechanisms

Selenium's anti-cancer effects operate through multiple pathways: GPx-mediated reduction of DNA-damaging ROS, TrxR-dependent regulation of p53 tumor suppressor activity, selenomethionine-mediated inhibition of angiogenesis, and selenium metabolites (methylselenol) that directly induce apoptosis in transformed cells. The U-shaped dose-response curve means both deficiency and excess increase cancer risk.

Immune Modulation

Selenium deficiency impairs both innate immunity (reduced macrophage and NK cell function) and adaptive immunity (decreased T-cell proliferation, impaired antibody responses). Mechanistically, selenoproteins in immune cells regulate ROS-dependent signaling that controls activation, proliferation, and differentiation. Selenium supplementation also reduces viral mutation rates by enhancing host antioxidant defenses in infected cells.

Research

Safety Profile

Safety Profile: Selenium

Common Side Effects

• Garlic-like breath odor (most characteristic sign of selenium intake at moderate-to-high doses)
• Mild gastrointestinal symptoms: nausea, diarrhea, and abdominal discomfort
• Metallic taste in the mouth
• Brittle hair and nails at chronic intakes approaching the tolerable upper limit (400 mcg/day)

Serious Adverse Effects

• Selenosis (chronic toxicity): occurs at chronic intakes above 400 mcg/day; symptoms include hair loss, nail brittleness and loss, skin rash, fatigue, irritability, peripheral neuropathy, and garlic breath; severe cases involve liver cirrhosis and pulmonary edema
• Acute selenium poisoning: extremely high single doses (>1 mg) can cause severe GI distress, cardiac arrhythmias, renal failure, and death; a 2008 supplement manufacturing error (200x intended dose) caused mass selenosis
• Type 2 diabetes risk: the SELECT trial and meta-analyses suggest that chronic selenium supplementation (200 mcg/day) in selenium-replete populations may increase type 2 diabetes incidence by 10–25%
• Prostate cancer: SELECT trial showed no cancer prevention benefit and a non-significant trend toward increased high-grade prostate cancer with selenium + vitamin E
• Skin cancer: the NPC trial showed increased non-melanoma skin cancer risk in selenium-supplemented individuals with higher baseline selenium levels

Contraindications

• Baseline serum selenium above 122 mcg/L (supplementation provides no benefit and increases toxicity risk)
• History of non-melanoma skin cancer (possible increased recurrence risk)
• Iodine deficiency (selenium supplementation without correcting iodine deficiency can worsen hypothyroidism by accelerating thyroid hormone metabolism)
• Known allergy to selenium compounds

Drug Interactions

• Cisplatin and other platinum-based chemotherapeutics: selenium may reduce efficacy through antioxidant antagonism of oxidative cytotoxicity; alternatively, some evidence suggests nephroprotective effects—always consult oncologist
• Statins: selenium combined with niacin, vitamin C, and vitamin E was shown to blunt the HDL-raising effect of simvastatin-niacin combination therapy
• Anticoagulants: high-dose selenium may have mild antiplatelet effects
• Barbiturates and sedatives: selenium may potentiate sedation in animal models
• Levothyroxine: selenium (as selenomethionine) is essential for deiodinase function; supplementation may alter T4-to-T3 conversion and necessitate thyroid dose adjustment

Population-Specific Considerations

• Thyroid health: selenium (200 mcg/day selenomethionine) reduces TPO antibodies in Hashimoto's thyroiditis; beneficial when baseline selenium is low; unnecessary when replete
• Pregnancy: RDA increases to 60 mcg/day; adequate selenium reduces preeclampsia risk; avoid exceeding 400 mcg/day
• Cancer prevention: evidence does NOT support supplementation in selenium-replete populations (>100 mcg/L plasma); potential harm in this group
• Elderly: increased vulnerability to selenosis due to reduced renal clearance; use lower doses
• Geographic consideration: selenium status varies enormously by region (low in parts of China and Europe; adequate-to-high in North America); check serum levels before supplementing

Pharmacokinetic Profile